The 2026 ACMG Annual Clinical Genetics Meeting will present both research and clinical topics that promote the science and the practice of clinical genetics and genomics. Sessions will focus on the latest discoveries of the etiology and the pathogenesis of genetic disorders, the latest developments in genetic testing and screening, the laboratory’s role in the diagnosis of genetic disorders, the treatment of genetic disorders in children and adults, the delivery of genetic services, and more.

See the Schedule-at-a-Glance.

Scientific Sessions

Short Courses offer in-depth explorations of specific topics. Additional fees apply.

Concurrent Scientific Sessions highlight a wide range of topics of interest to genetics practitioners, laboratorians, researchers, counselors and others with an interest in the science and art of medical genetics.

Scientific Plenary Sessions focus on one topic or area, as well as trends.

Selected Abstract Presentations will be presented as Platform Presentations or as posters in the Exhibit Hall. An online Poster Gallery will also be available for continued viewing after the meeting.

Student Session

Pathways to Genetics Careers 

This session will provide undergraduate, graduate, genetic counseling and medical students with the opportunity to learn more about a career in the field of Medical Genetics, including its various component training pathways. The session will consist of insights into the different career pathways in Medical Genetics with presentations by a clinical academic geneticist, a clinical laboratory-based geneticist, a genetic counselor, a medical genetics resident/recent graduate, and a geneticist representing the American Board of Medical Genetics and Genomics.

Additional Learning Opportunities

Industry Supported Satellite Symposia offer industry and related organizations the opportunity to host non-commercial, grant-supported educational satellite sessions in conjunction with the meeting, enhancing the educational experience for attendees. These educational activities are presented with objectivity, balance and scientific rigor. They are planned solely by the sponsoring company, ACCME providers, medical education companies and/or non-profit organizations. These activities are not part of the official ACMG meeting programming and are not accredited by ACMG. Separate registration for the symposia is required. 

Exhibit Theaters are half-hour sessions presented by exhibiting companies. These sessions showcase recent developments and applications of their products, techniques, and/or services and demonstrate how the product or service is used in practical and/or clinical settings. These sessions are not approved for educational credits.

ACMG Foundation Corporate Partner Insights Sessions are one-hour lunchtime sessions presented by the ACMG Foundation’s Corporate Partners. These provide an opportunity for this group of ACMG Foundation supporters to share valuable insights into the latest industry trends, innovations, and developments of their company in the ever-evolving landscape of genomic medicine.  Whether it's exploring cutting-edge technologies, new products, or sharing best practices, these sessions aim to foster collaboration between Industry and genetics professionals.  These sessions are commercially supported activities held in conjunction with the ACMG Meeting. They are not awarded educational credit by ACMG.

Target Audience

All healthcare professionals interested in the diagnosis, management, treatment, and prevention of genetic conditions and increasing their understanding of the genetic basis of common, chronic health problems affecting both children and adults will find the programming applicable to their practice. The ACMG Annual Meeting is targeted for the following professionals:

  • Medical and clinical geneticists; laboratory geneticists and pathologists; genetic counselors; pediatric, obstetric, and maternal-fetal specialists; and all medical practitioners who are providing comprehensive diagnostic, management, and counseling services for individuals with, or at risk for, genetically influenced health problems.
  • Laboratory professionals who conduct genetic testing.
  • Researchers involved in the discovery of genetic disorders, pathogenic mechanisms and treatments.
  • Clinical, laboratory and research trainees of genetics and all biomedical sciences.
  • Educators, trainees, healthcare and public health professionals who have an interest in medical and clinical genetics and genomics.
  • Advocates for individuals with genetic conditions and their families

Learning Objectives

At the conclusion of this course, participants should be able to:

  • Describe the recent advances in laboratory genetic testing including prenatal and postnatal indications, constitutional and somatic cancer testing, emerging technologies, and variant interpretation.
  • Review topics covering a range of rare and common genetic conditions, including management and treatment, genetic counseling, and ethical and legal issues.
  • Describe emerging novel therapeutics, including gene therapies, and evaluate their potential applications, mechanisms of action, and clinical care implications.
  • Review select inborn errors of metabolism, newborn screening, and current diagnostic and treatment approaches.
  • Recognize the importance of community, outreach, engagement and advocacy in clinical genetic care, research, and genetic workforce development.
  • Analyze the need for innovation, interdisciplinary collaboration with other medical specialties, and new approaches to advance the practice of genetic medicine toward a vision of genomically-informed precision population health.